High | Q04206 | Transcription factor p65 OS=Homo sapiens OX=9606 GN=RELA PE=1 SV=2 | 0.001 | 2.746 | 3 | 2 | 2 | 2 | 551 | 60.2 | 5.68 | 1 | 1 | | | 1 | 1 | | | 2015648.188 | 1747456.422 | 2143345.492 | 2073695.375 | 2 | 2 | 2 | 1 | | defense response;metabolic process;regulation of biological process;response to stimulus | cytoplasm;cytosol;nucleus | DNA binding;protein binding | Pf00554 | 5970 | ENSG00000173039.18 | RELA | 11 | CLEC7A/inflammasome pathway; IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR); Regulated proteolysis of p75NTR; Downstream TCR signaling; Transcriptional regulation of white adipocyte differentiation; TRAF6 mediated NF-kB activation; TAK1 activates NFkB by phosphorylation and activation of IKKs complex; RIP-mediated NFkB activation via ZBP1; Activated TLR4 signalling; Interleukin-1 processing; PKMTs methylate histone lysines; FCERI mediated NF-kB activation; CD209 (DC-SIGN) signaling; Activation of NF-kappaB in B cells; DEx/H-box helicases activate type I IFN and inflammatory cytokines production ; NF-kB is activated and signals survival; Dectin-1 mediated noncanonical NF-kB signaling; Signalling by NGF; IkBA variant leads to EDA-ID; Senescence-Associated Secretory Phenotype (SASP) | Viral carcinogenesis; Chagas disease (American trypanosomiasis); Th1 and Th2 cell differentiation; Inflammatory bowel disease (IBD); Amoebiasis; T cell receptor signaling pathway; TNF signaling pathway; NOD-like receptor signaling pathway; Osteoclast differentiation; Hepatitis B; HIF-1 signaling pathway; Pancreatic cancer; Prolactin signaling pathway; Chronic myeloid leukemia; Antifolate resistance; Epstein-Barr virus infection; Neurotrophin signaling pathway; B cell receptor signaling pathway; Leishmaniasis; Acute myeloid leukemia; MAPK signaling pathway; Pathways in cancer; Prostate cancer; NF-kappa B signaling pathway; AGE-RAGE signaling pathway in diabetic complications; Tuberculosis; Pertussis; HTLV-I infection; Toxoplasmosis; Apoptosis; Cytosolic DNA-sensing pathway; Salmonella infection; Transcriptional misregulation in cancer; Non-alcoholic fatty liver disease (NAFLD); Cocaine addiction; Sphingolipid signaling pathway; Measles; Small cell lung cancer; Toll-like receptor signaling pathway; Herpes simplex infection; Hepatitis C; Ras signaling pathway; RIG-I-like receptor signaling pathway; Epithelial cell signaling in Helicobacter pylori infection; Chemokine signaling pathway; cAMP signaling pathway; Influenza A; Legionellosis; Insulin resistance; Adipocytokine signaling pathway; Longevity regulating pathway; PI3K-Akt signaling pathway; Shigellosis | 0 |